Apimeds Pharmaceuticals Us I

CUSIP 03771D102COM SHSAPUSQ4 2025

Apimeds Pharmaceuticals Us I — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

37.9%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

3 filings · latest Feb 11, 2026

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Feb 11, 2026	Ayrton Capital LLC	13G	10.0%	1.40M	SEC
2	Jan 26, 2026	Inscobee Inc.	13D/A	34.3%	—	SEC
3	May 19, 2025	Inscobee Inc.	13D	37.9%	—	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Hemenway Trust Co LLC	274.0K	$449.4K
2	Vanguard Group Inc	59.0K	$96.7K
3	Geode Capital Management, LLC	34.9K	$57.2K
4	Jane Street Group, LLC	27.2K	$44.6K
5	Ubs Group AG	582	$954
6	Bank Of America Corp /De/	40	$66
7	Tower Research Capital LLC (Trc)	10	$16